Nasdaq
MBX
MBX Biosciences, Inc.
- Health Care
- Listed 2024
- 1 day
- −0.5%
- 1 month
- +8.2%
- 1 year
- +475%
$67.11 · Mkt cap $3.19B
At the 6 Aug 2026 close
Nasdaq
MBX Biosciences, Inc.
$67.11 · Mkt cap $3.19B
At the 6 Aug 2026 close
MBX Biosciences, Inc. trades under the ticker MBX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2024. Its market capitalisation is $3.19B. The last closing price was $67.11, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +475%, and +8.2% over the past month. Returns are price returns and exclude dividends.
This page exists because MBX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.